mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.2 |
mRNA |
RDEA119 |
FIMM |
pan-cancer |
AAC |
0.19 |
0.2 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
0.038 |
0.2 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.2 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
JW-7-52-1 |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.2 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.2 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.3 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.058 |
0.3 |